Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.

Source:http://linkedlifedata.com/resource/pubmed/id/12924933

Biochemistry 2003 Aug 26 42 33 9841-53

Download in:

View as

General Info

PMID
12924933